Has the incidence of multiple myeloma in old age been underestimated?
- 1 November 1991
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 47 (5) , 333-337
- https://doi.org/10.1111/j.1600-0609.1991.tb01856.x
Abstract
All patients in the region with newly discovered M components were registered from 15 Aug. 1984-31 Dec. 1986. Among a total of 393 patients enrolled, 162 had multiple myeloma (MM). The incidence rate was 6.6 per 100,000 population per year (age-adjusted to the European standard population), which is somewhat higher than previous reports based on hospital and autopsy records. In particular, the incidence rate was higher in the greater than 70 age group. Thus, the median age was 72 yr, which is the highest reported. As many as 71 (44%) of the 162 MM patients were asymptomatic; these asymptomatic patients had the same age distribution as the symptomatic ones. The stage distribution, occurrence of risk factors, response to chemotherapy, response duration and survival were similar in the age groups below and above the median and, in multivariate survival analysis, age was not an independent risk factor.Keywords
This publication has 22 references indexed in Scilit:
- Multiple myeloma in central and northern Norway 1981-1982: A follow-up study of a randomized clinical trial of 5-drug combination therapy versus standard therapyEuropean Journal of Haematology, 2009
- Incidence and follow‐up of asymptomatic multiple myeloma.European Journal of Haematology, 1991
- Melphalan/prednisone versus drug combinations for plasma cell myelomaEuropean Journal of Haematology, 1989
- The Merlini, Waldenström, Jayakar staging system revisitedEuropean Journal of Haematology, 1989
- INTENSIVE TREATMENT OF MULTIPLE MYELOMA AND CRITERIA FOR COMPLETE REMISSIONThe Lancet, 1989
- Treatment of multiple myeloma in old patientsEuropean Journal of Haematology, 1989
- Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III —A randomized study from MGCSEuropean Journal of Haematology, 1989
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- Comparison of Trends in the Incidence of Multiple Myeloma in Malmö, Sweden, and Other Countries, 1950–1979New England Journal of Medicine, 1984
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958